論文

査読有り
2009年

Management for patients with de novo or recurrent tumors in the residual kidney after surgery for nonfamilial bilateral renal cell carcinoma

Advances in Urology
  • Noboru Hara
  • ,
  • Tsutomu Nishiyama
  • ,
  • Norihiko Yoshimura
  • ,
  • Satoshi Takaki
  • ,
  • Kyoichiro Yamakado
  • ,
  • Yasuo Kitamura
  • ,
  • Kazuya Suzuki
  • ,
  • Kota Takahashi

開始ページ
135143
終了ページ
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1155/2009/135143

The tumor de novo in the residual kidney after surgery for nonfamilial bilateral renal cell carcinoma (RCC) is problematic. We reviewed 5 patients who experienced such a situation. Three patients had had metachronous bilateral RCC, treated with radical nephrectomy in one kidney and nephron-sparing surgery (NSS) in the other. Two patients had had synchronous disease
one patient had received radical nephrectomy and NSS, and the other bilateral NSS. The 5 patients had another solid mass/de novo tumor in the residual kidney 16-88 (mean 46.8) months after surgery. For the tumor de novo in earlier years (1992-1999), one patient underwent surgery and hemodialysis, and the other selected a conservative observation. In recent years (2000-2007), one patient was conservatively observed
the remaining 2 received computerized-tomography-guided radiofrequency ablation, and the local tumors were well controlled postoperatively for 20 and 12 months with their renal function unimpaired. Ablative techniques can potentially strike a balance between oncological and nephrological outcomes in patients with sporadic multiple RCC, successful management of which was difficult previously. © 2009 Noboru Hara et al.

リンク情報
DOI
https://doi.org/10.1155/2009/135143
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/19997515
ID情報
  • DOI : 10.1155/2009/135143
  • ISSN : 1687-6369
  • ISSN : 1687-6377
  • PubMed ID : 19997515
  • SCOPUS ID : 73449092219

エクスポート
BibTeX RIS